ARCHIVES

Vaccine Increases PFS by 4 Months In Phase II Per-Protocol Analysis

This article is from The Cancer Letter archive.

Vol. 37 No. 6 | June 27, 2014

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

New Drug Combination Improves Survival Of Ewing’s Sarcoma, Pediatric Study Finds

February 28, 2003

Schering to Pay $435M to Settle Federal Charges.

January 26, 2007

Congressman Obey Attacks NCI for Not Supporting Basic Research

January 23, 1976

Funding Opportunities: NCI Offers Funds To Develop, Validate Mouse Models

November 20, 1998

In Brief: The Children’s Oncology Group Is Name for Pediatric Trials Groups In Merger

June 25, 1999